Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S2W-06891 · Session 2

Further to the answer to question S2W-6071 by Malcolm Chisholm on 5 March 2004, what the reasons are for its decision not to arrange for cl…

Answered Asked by Alasdair Morgan SNP Lodged 11 Mar 2004

The question

To ask the Scottish Executive, further to the answer to question S2W-6071 by Malcolm Chisholm on 5 March 2004, what the reasons are for its decision not to arrange for clinical trials of the anti-dementia drug memantine (Exiba).

The answer

Answered by Malcolm Chisholm on 22 Mar 2004 · 11 days after it was lodged, on time

The Scottish Executiveencourages patient entry into clinical trials but has no locus in setting theseup.

In the Official Report

No contribution in the Official Report cites S2W-06891 by reference.